Neuberger Berman Group LLC Bristol Myers Squibb CO Transaction History
Neuberger Berman Group LLC
- $123 Billion
- Q3 2024
A detailed history of Neuberger Berman Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,801,412 shares of BMY stock, worth $104 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,801,412
Previous 584,276
208.32%
Holding current value
$104 Million
Previous $24.3 Million
284.2%
% of portfolio
0.08%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,532Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.18 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.38 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.51 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...